Product record

Haloperidol: batches declared Not of Standard Quality

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts, Jan 2019 to Sep 2026

2 batches of products named "Haloperidol" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between February 2025 and August 2026. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.

Records by type

2 records linked to Haloperidol in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2025 to Aug 2026

View original document

Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches
2
Manufacturers
Sterility
Most common reason
Aug 2026
Latest alert

Flagged batches

Batch Manufacturer Reason declared NSQ Tested by Alert
Batch HP404Mfg May 2024 · Exp Apr 2027 Tamman Titoe Pharma Pvt. Ltd The sample does not comply as per I.P. 2022 with respect to the test for Sterility.Sterility RDTL, GuwahatiCDSCO lab Aug 2026
Batch L2403/2Mfg Mar 2024 · Exp Feb 2026 SBS BiotechHimachal Pradesh Particulate matter and DescriptionDescription CDL KolkataCDSCO lab Feb 2025

How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of September 2026. Check any batch number.